APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiolabeled Compounds Synthesis Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Radiolabeled Compounds Synthesis Service Market Analysis and Forecast 2026-2032

28 December 2025198 pages

Choose your research edition.

Industry ResearchRadiolabeled Compounds Synthesis Service Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiolabeled Compounds Synthesis Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Radiolabeled Compounds Synthesis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiolabeled Compounds Synthesis Service Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiolabeled Compounds Synthesis Service Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Radiolabeled Compounds Synthesis Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Radiolabeled Compounds Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Radiolabeled Compounds Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Radiolabeled Compounds Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Radiolabeled Compounds Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Radiolabeled Compounds Synthesis Service include Eurofins, Revvity, Selcia, Labcorp, Pharmaron, WuXi AppTec, AM Chemicals, SEKISUI MEDICAL CO., LTD. and Nuvisan, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Radiolabeled Compounds Synthesis Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Radiolabeled Compounds Synthesis Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Radiolabeled Compounds Synthesis Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radiolabeled Compounds Synthesis Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Radiolabeled Compounds Synthesis Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Radiolabeled Compounds Synthesis Service revenue, projected growth trends, production technology, application and end-user industry.

Radiolabeled Compounds Synthesis Service Segment by Company

Eurofins

Revvity

Selcia

Labcorp

Pharmaron

WuXi AppTec

AM Chemicals

SEKISUI MEDICAL CO., LTD.

Nuvisan

Almac

Novandi Chemistry

Alfa Cytology

Institute of Isotopes Co. Ltd.

Headway

ViTrax

Radiolabeled Compounds Synthesis Service Segment by Type

Carbon-14 Radiosynthesis Services

Hydrogen-3 Radiosynthesis Services

Chiral Separation and Salt Formation

Others

Radiolabeled Compounds Synthesis Service Segment by Application

Medical Diagnosis and Treatment

Material Science

Nuclear Energy

Others

Radiolabeled Compounds Synthesis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiolabeled Compounds Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiolabeled Compounds Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiolabeled Compounds Synthesis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Radiolabeled Compounds Synthesis Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Radiolabeled Compounds Synthesis Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiolabeled Compounds Synthesis Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Radiolabeled Compounds Synthesis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Carbon-14 Radiosynthesis Services Major Player Table 3. Hydrogen-3 Radiosynthesis Services Major Player Table 4. Chiral Separation and Salt Formation Major Player Table 5. Others Major Player Table 6. Global Radiolabeled Compounds Synthesis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Medical Diagnosis and Treatment Major Player Table 8. Material Science Major Player Table 9. Nuclear Energy Major Player Table 10. Others Major Player Table 11. Radiolabeled Compounds Synthesis Service Industry Trends Table 12. Radiolabeled Compounds Synthesis Service Industry Drivers Table 13. Radiolabeled Compounds Synthesis Service Industry Opportunities and Challenges Table 14. Radiolabeled Compounds Synthesis Service Industry Restraints Table 15. Global Radiolabeled Compounds Synthesis Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Radiolabeled Compounds Synthesis Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Radiolabeled Compounds Synthesis Service Market Share by Region (2021-2026) Table 18. Global Radiolabeled Compounds Synthesis Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Radiolabeled Compounds Synthesis Service Market Share by Region (2027-2032) Table 20. Global Radiolabeled Compounds Synthesis Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Players (2021-2026) Table 22. Global Radiolabeled Compounds Synthesis Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Radiolabeled Compounds Synthesis Service Key Players Headquarters & Area Served Table 24. Global Radiolabeled Compounds Synthesis Service Players, Product Type & Application Table 25. Global Radiolabeled Compounds Synthesis Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Radiolabeled Compounds Synthesis Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Radiolabeled Compounds Synthesis Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Type (2021-2026) Table 32. Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Type (2027-2032) Table 33. Global Radiolabeled Compounds Synthesis Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Application (2021-2026) Table 37. Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Application (2027-2032) Table 38. Eurofins Company Information Table 39. Eurofins Business Overview Table 40. Eurofins Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Eurofins Radiolabeled Compounds Synthesis Service Product Portfolio Table 42. Eurofins Recent Development Table 43. Revvity Company Information Table 44. Revvity Business Overview Table 45. Revvity Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Revvity Radiolabeled Compounds Synthesis Service Product Portfolio Table 47. Revvity Recent Development Table 48. Selcia Company Information Table 49. Selcia Business Overview Table 50. Selcia Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Selcia Radiolabeled Compounds Synthesis Service Product Portfolio Table 52. Selcia Recent Development Table 53. Labcorp Company Information Table 54. Labcorp Business Overview Table 55. Labcorp Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Labcorp Radiolabeled Compounds Synthesis Service Product Portfolio Table 57. Labcorp Recent Development Table 58. Pharmaron Company Information Table 59. Pharmaron Business Overview Table 60. Pharmaron Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Pharmaron Radiolabeled Compounds Synthesis Service Product Portfolio Table 62. Pharmaron Recent Development Table 63. WuXi AppTec Company Information Table 64. WuXi AppTec Business Overview Table 65. WuXi AppTec Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. WuXi AppTec Radiolabeled Compounds Synthesis Service Product Portfolio Table 67. WuXi AppTec Recent Development Table 68. AM Chemicals Company Information Table 69. AM Chemicals Business Overview Table 70. AM Chemicals Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. AM Chemicals Radiolabeled Compounds Synthesis Service Product Portfolio Table 72. AM Chemicals Recent Development Table 73. SEKISUI MEDICAL CO., LTD. Company Information Table 74. SEKISUI MEDICAL CO., LTD. Business Overview Table 75. SEKISUI MEDICAL CO., LTD. Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. SEKISUI MEDICAL CO., LTD. Radiolabeled Compounds Synthesis Service Product Portfolio Table 77. SEKISUI MEDICAL CO., LTD. Recent Development Table 78. Nuvisan Company Information Table 79. Nuvisan Business Overview Table 80. Nuvisan Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Nuvisan Radiolabeled Compounds Synthesis Service Product Portfolio Table 82. Nuvisan Recent Development Table 83. Almac Company Information Table 84. Almac Business Overview Table 85. Almac Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Almac Radiolabeled Compounds Synthesis Service Product Portfolio Table 87. Almac Recent Development Table 88. Novandi Chemistry Company Information Table 89. Novandi Chemistry Business Overview Table 90. Novandi Chemistry Radiolabeled Compounds Synthesis Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Novandi Chemistry Radiolabeled Compounds Synthesis Service Product Portfolio Table 92. Novandi Chemistry Recent Development Table 93. Alfa Cytology Company Information Table 94. Alfa Cytology Business Overview Table 95. Alfa Cytology Radiolabeled Compounds Synthesis Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Alfa Cytology Radiolabeled Compounds Synthesis Service Product Portfolio Table 97. Alfa Cytology Recent Development Table 98. Institute of Isotopes Co. Ltd. Company Information Table 99. Institute of Isotopes Co. Ltd. Business Overview Table 100. Institute of Isotopes Co. Ltd. Radiolabeled Compounds Synthesis Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Institute of Isotopes Co. Ltd. Radiolabeled Compounds Synthesis Service Product Portfolio Table 102. Institute of Isotopes Co. Ltd. Recent Development Table 103. Headway Company Information Table 104. Headway Business Overview Table 105. Headway Radiolabeled Compounds Synthesis Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Headway Radiolabeled Compounds Synthesis Service Product Portfolio Table 107. Headway Recent Development Table 108. ViTrax Company Information Table 109. ViTrax Business Overview Table 110. ViTrax Radiolabeled Compounds Synthesis Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. ViTrax Radiolabeled Compounds Synthesis Service Product Portfolio Table 112. ViTrax Recent Development Table 113. North America Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 116. North America Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 117. North America Radiolabeled Compounds Synthesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Radiolabeled Compounds Synthesis Service Revenue by Country (2021-2026) & (US$ Million) Table 119. North America Radiolabeled Compounds Synthesis Service Revenue by Country (US$ Million) & (2027-2032) Table 120. Europe Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Radiolabeled Compounds Synthesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe Radiolabeled Compounds Synthesis Service Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Radiolabeled Compounds Synthesis Service Revenue by Country (US$ Million) & (2027-2032) Table 127. China Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 128. China Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 129. China Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 130. China Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 132. Asia Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 133. Asia Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 134. Asia Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Radiolabeled Compounds Synthesis Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Asia Radiolabeled Compounds Synthesis Service Revenue by Region (US$ Million) & (2021-2026) Table 137. Asia Radiolabeled Compounds Synthesis Service Revenue by Region (US$ Million) & (2027-2032) Table 138. SAMEA Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 139. SAMEA Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 140. SAMEA Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 141. SAMEA Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 142. SAMEA Radiolabeled Compounds Synthesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. SAMEA Radiolabeled Compounds Synthesis Service Revenue by Country (2021-2026) & (US$ Million) Table 144. SAMEA Radiolabeled Compounds Synthesis Service Revenue by Country (US$ Million) & (2027-2032) Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Radiolabeled Compounds Synthesis Service Image Figure 2. Global Radiolabeled Compounds Synthesis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiolabeled Compounds Synthesis Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Carbon-14 Radiosynthesis Services Image Figure 5. Hydrogen-3 Radiosynthesis Services Image Figure 6. Chiral Separation and Salt Formation Image Figure 7. Others Image Figure 8. Global Radiolabeled Compounds Synthesis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Radiolabeled Compounds Synthesis Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Medical Diagnosis and Treatment Image Figure 11. Material Science Image Figure 12. Nuclear Energy Image Figure 13. Others Image Figure 14. Global Radiolabeled Compounds Synthesis Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Radiolabeled Compounds Synthesis Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Radiolabeled Compounds Synthesis Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Radiolabeled Compounds Synthesis Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Radiolabeled Compounds Synthesis Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Radiolabeled Compounds Synthesis Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Type (2021-2032) Figure 22. Global Radiolabeled Compounds Synthesis Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Application (2021-2032) Figure 25. North America Radiolabeled Compounds Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032) Figure 27. North America Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032) Figure 28. North America Radiolabeled Compounds Synthesis Service Revenue Share by Country (2021-2032) Figure 29. United States Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Radiolabeled Compounds Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032) Figure 34. Europe Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032) Figure 35. Europe Radiolabeled Compounds Synthesis Service Revenue Share by Country (2021-2032) Figure 36. Germany Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Radiolabeled Compounds Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032) Figure 46. China Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032) Figure 47. Asia Radiolabeled Compounds Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032) Figure 49. Asia Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032) Figure 50. Asia Radiolabeled Compounds Synthesis Service Revenue Share by Region (2021-2032) Figure 51. Japan Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Radiolabeled Compounds Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Radiolabeled Compounds Synthesis Service Revenue Share by Country (2021-2032) Figure 61. Brazil Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Radiolabeled Compounds Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Carbon-14 Radiosynthesis Services
  • Hydrogen-3 Radiosynthesis Services
  • Chiral Separation and Salt Formation
  • Others
Applications
  • Medical Diagnosis and Treatment
  • Material Science
  • Nuclear Energy
  • Others
Companies covered
  • Eurofins
  • Revvity
  • Selcia
  • Labcorp
  • Pharmaron
  • WuXi AppTec
  • AM Chemicals
  • SEKISUI MEDICAL CO., LTD.
  • Nuvisan
  • Almac
  • Novandi Chemistry
  • Alfa Cytology
  • Institute of Isotopes Co. Ltd.
  • Headway
  • ViTrax

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Radiolabeled Compounds Synthesis Service Market by Type
  3. 1.2.1 Global Radiolabeled Compounds Synthesis Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Carbon-14 Radiosynthesis Services
  5. 1.2.3 Hydrogen-3 Radiosynthesis Services
  6. 1.2.4 Chiral Separation and Salt Formation
  7. 1.2.5 Others
  8. 1.3 Radiolabeled Compounds Synthesis Service Market by Application
  9. 1.3.1 Global Radiolabeled Compounds Synthesis Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Medical Diagnosis and Treatment
  11. 1.3.3 Material Science
  12. 1.3.4 Nuclear Energy
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Radiolabeled Compounds Synthesis Service Market Dynamics
  1. 2.1 Radiolabeled Compounds Synthesis Service Industry Trends
  2. 2.2 Radiolabeled Compounds Synthesis Service Industry Drivers
  3. 2.3 Radiolabeled Compounds Synthesis Service Industry Opportunities and Challenges
  4. 2.4 Radiolabeled Compounds Synthesis Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Radiolabeled Compounds Synthesis Service Market Perspective (2021-2032)
  2. 3.2 Global Radiolabeled Compounds Synthesis Service Growth Trends by Region
  3. 3.2.1 Global Radiolabeled Compounds Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Radiolabeled Compounds Synthesis Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Radiolabeled Compounds Synthesis Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Radiolabeled Compounds Synthesis Service Revenue by Players
  2. 4.1.1 Global Radiolabeled Compounds Synthesis Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Radiolabeled Compounds Synthesis Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Radiolabeled Compounds Synthesis Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Radiolabeled Compounds Synthesis Service Key Players Headquarters & Area Served
  7. 4.4 Global Radiolabeled Compounds Synthesis Service Players, Product Type & Application
  8. 4.5 Global Radiolabeled Compounds Synthesis Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Radiolabeled Compounds Synthesis Service Market CR5 and HHI
  11. 4.6.3 2025 Radiolabeled Compounds Synthesis Service Tier 1, Tier 2, and Tier 3
5 Radiolabeled Compounds Synthesis Service Market Size by Type
  1. 5.1 Global Radiolabeled Compounds Synthesis Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2032)
  3. 5.3 Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Type (2021-2032)
6 Radiolabeled Compounds Synthesis Service Market Size by Application
  1. 6.1 Global Radiolabeled Compounds Synthesis Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2032)
  3. 6.3 Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eurofins
  2. 7.1.1 Eurofins Company Information
  3. 7.1.2 Eurofins Business Overview
  4. 7.1.3 Eurofins Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eurofins Radiolabeled Compounds Synthesis Service Product Portfolio
  6. 7.1.5 Eurofins Recent Developments
  7. 7.2 Revvity
  8. 7.2.1 Revvity Company Information
  9. 7.2.2 Revvity Business Overview
  10. 7.2.3 Revvity Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Revvity Radiolabeled Compounds Synthesis Service Product Portfolio
  12. 7.2.5 Revvity Recent Developments
  13. 7.3 Selcia
  14. 7.3.1 Selcia Company Information
  15. 7.3.2 Selcia Business Overview
  16. 7.3.3 Selcia Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Selcia Radiolabeled Compounds Synthesis Service Product Portfolio
  18. 7.3.5 Selcia Recent Developments
  19. 7.4 Labcorp
  20. 7.4.1 Labcorp Company Information
  21. 7.4.2 Labcorp Business Overview
  22. 7.4.3 Labcorp Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Labcorp Radiolabeled Compounds Synthesis Service Product Portfolio
  24. 7.4.5 Labcorp Recent Developments
  25. 7.5 Pharmaron
  26. 7.5.1 Pharmaron Company Information
  27. 7.5.2 Pharmaron Business Overview
  28. 7.5.3 Pharmaron Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pharmaron Radiolabeled Compounds Synthesis Service Product Portfolio
  30. 7.5.5 Pharmaron Recent Developments
  31. 7.6 WuXi AppTec
  32. 7.6.1 WuXi AppTec Company Information
  33. 7.6.2 WuXi AppTec Business Overview
  34. 7.6.3 WuXi AppTec Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 WuXi AppTec Radiolabeled Compounds Synthesis Service Product Portfolio
  36. 7.6.5 WuXi AppTec Recent Developments
  37. 7.7 AM Chemicals
  38. 7.7.1 AM Chemicals Company Information
  39. 7.7.2 AM Chemicals Business Overview
  40. 7.7.3 AM Chemicals Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 AM Chemicals Radiolabeled Compounds Synthesis Service Product Portfolio
  42. 7.7.5 AM Chemicals Recent Developments
  43. 7.8 SEKISUI MEDICAL CO., LTD.
  44. 7.8.1 SEKISUI MEDICAL CO., LTD. Company Information
  45. 7.8.2 SEKISUI MEDICAL CO., LTD. Business Overview
  46. 7.8.3 SEKISUI MEDICAL CO., LTD. Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 SEKISUI MEDICAL CO., LTD. Radiolabeled Compounds Synthesis Service Product Portfolio
  48. 7.8.5 SEKISUI MEDICAL CO., LTD. Recent Developments
  49. 7.9 Nuvisan
  50. 7.9.1 Nuvisan Company Information
  51. 7.9.2 Nuvisan Business Overview
  52. 7.9.3 Nuvisan Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Nuvisan Radiolabeled Compounds Synthesis Service Product Portfolio
  54. 7.9.5 Nuvisan Recent Developments
  55. 7.10 Almac
  56. 7.10.1 Almac Company Information
  57. 7.10.2 Almac Business Overview
  58. 7.10.3 Almac Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Almac Radiolabeled Compounds Synthesis Service Product Portfolio
  60. 7.10.5 Almac Recent Developments
  61. 7.11 Novandi Chemistry
  62. 7.11.1 Novandi Chemistry Company Information
  63. 7.11.2 Novandi Chemistry Business Overview
  64. 7.11.3 Novandi Chemistry Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Novandi Chemistry Radiolabeled Compounds Synthesis Service Product Portfolio
  66. 7.11.5 Novandi Chemistry Recent Developments
  67. 7.12 Alfa Cytology
  68. 7.12.1 Alfa Cytology Company Information
  69. 7.12.2 Alfa Cytology Business Overview
  70. 7.12.3 Alfa Cytology Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Alfa Cytology Radiolabeled Compounds Synthesis Service Product Portfolio
  72. 7.12.5 Alfa Cytology Recent Developments
  73. 7.13 Institute of Isotopes Co. Ltd.
  74. 7.13.1 Institute of Isotopes Co. Ltd. Company Information
  75. 7.13.2 Institute of Isotopes Co. Ltd. Business Overview
  76. 7.13.3 Institute of Isotopes Co. Ltd. Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Institute of Isotopes Co. Ltd. Radiolabeled Compounds Synthesis Service Product Portfolio
  78. 7.13.5 Institute of Isotopes Co. Ltd. Recent Developments
  79. 7.14 Headway
  80. 7.14.1 Headway Company Information
  81. 7.14.2 Headway Business Overview
  82. 7.14.3 Headway Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Headway Radiolabeled Compounds Synthesis Service Product Portfolio
  84. 7.14.5 Headway Recent Developments
  85. 7.15 ViTrax
  86. 7.15.1 ViTrax Company Information
  87. 7.15.2 ViTrax Business Overview
  88. 7.15.3 ViTrax Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 ViTrax Radiolabeled Compounds Synthesis Service Product Portfolio
  90. 7.15.5 ViTrax Recent Developments
8 North America
  1. 8.1 North America Radiolabeled Compounds Synthesis Service Revenue (2021-2032)
  2. 8.2 North America Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032)
  5. 8.3 North America Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032)
  9. 8.5 North America Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Radiolabeled Compounds Synthesis Service Revenue by Country
  11. 8.6.1 North America Radiolabeled Compounds Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Radiolabeled Compounds Synthesis Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Radiolabeled Compounds Synthesis Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Radiolabeled Compounds Synthesis Service Revenue (2021-2032)
  2. 9.2 Europe Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032)
  5. 9.3 Europe Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032)
  9. 9.5 Europe Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Radiolabeled Compounds Synthesis Service Revenue by Country
  11. 9.6.1 Europe Radiolabeled Compounds Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Radiolabeled Compounds Synthesis Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Radiolabeled Compounds Synthesis Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Radiolabeled Compounds Synthesis Service Revenue (2021-2032)
  2. 10.2 China Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2032)
  3. 10.2.1 China Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026)
  4. 10.2.2 China Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032)
  5. 10.3 China Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032)
  6. 10.4 China Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2032)
  7. 10.4.1 China Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026)
  8. 10.4.2 China Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032)
  9. 10.5 China Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Radiolabeled Compounds Synthesis Service Revenue (2021-2032)
  2. 11.2 Asia Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032)
  5. 11.3 Asia Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032)
  9. 11.5 Asia Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Radiolabeled Compounds Synthesis Service Revenue by Country
  11. 11.6.1 Asia Radiolabeled Compounds Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Radiolabeled Compounds Synthesis Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Radiolabeled Compounds Synthesis Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Radiolabeled Compounds Synthesis Service Revenue (2021-2032)
  2. 12.2 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Country
  11. 12.6.1 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst